ELI LILLY & Co (LLY) stock
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3025% above fair value
$1415.55−16.12 (-1.13%)
Close on Nov 17, 2026Market cap $1.33TP/E 45.9Yield 0.44%
Eli Lilly market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Eli Lilly's market cap was $1.29T on Nov 11, 2026, against $968.57B a year earlier. Over the last 5 years it ranged from $223.79B to $1.29T, with a median of $688.34B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.29T | +33.2% |
| 2025 | Dec 31, 2025 | $967.86B | +38.6% |
| 2024 | Dec 31, 2024 | $698.06B | +32.7% |
| 2023 | Dec 29, 2023 | $526.20B | +58.7% |
| 2022 | Dec 30, 2022 | $331.52B | +31.6% |
| 2021 | Dec 31, 2021 | $251.91B | +63.5% |
| 2020 | Dec 31, 2020 | $154.05B | +21.8% |
| 2019 | Dec 31, 2019 | $126.45B | +5.5% |
| 2018 | Dec 31, 2018 | $119.87B | +34.1% |
| 2017 | Dec 29, 2017 | $89.39B | +14.4% |
| 2016 | Dec 30, 2016 | $78.13B | -13.1% |
| 2015 | Dec 31, 2015 | $89.90B | +20.1% |
| 2014 | Dec 31, 2014 | $74.84B | +25.1% |
| 2013 | Jan 31, 2013 | $59.81B | +8.9% |
| 2012 | Dec 31, 2012 | $54.94B | – |
See a number that looks wrong?